ArticleJAMA network open2022

Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020.

Mayookha Mitra-Majumdar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.